Financials
By Josh White
Date: Monday 07 Jun 2021
(Sharecast News) - Life sciences investment company NetScientific announced on Monday that its subsidiary ProAxsis has entered into an exclusive licensing agreement with AstraZeneca.
By Josh White
Date: Thursday 10 Dec 2020
(Sharecast News) - Technology commercialisation company NetScientific announced on Thursday that its portfolio company ProAxsis has been awarded a high impact Innovate UK grant, as part of the recent 'UKRI Ideas to Address Covid-19' competition.
By Josh White
Date: Thursday 19 Nov 2020
(Sharecast News) - Life sciences, technology investment and commercialisation company NetScientific announced on Thursday that its portfolio company ProAxsis has appointed DiaPharma Group as the exclusive distributor of its portfolio of respiratory research assays for the key North America region.
Currency | UK Pounds |
Share Price | 64.30p |
Change Today | 1.30p |
% Change | 2.07 % |
52 Week High | 79.50 |
52 Week Low | 49.00 |
Volume | 0 |
Shares Issued | 23.95m |
Market Cap | £15.40m |
RiskGrade | 410 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
CEO | Ilian Iliev |
CFO | Stephen Crowe |
You are here: research